Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy

J. Breuer-McHam, G. Marshall, A. Adu-Oppong, M. Goller, S. Mays, T. Berger, D. E. Lewis, M. Duvic

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Background: Ultraviolet light (UVL) upregulates HIV transcription in vitro and in transgenic mice. AIDS-associated psoriasis and pruritus respond to phototherapy. Objective: Our goal was to determine the effect of phototherapy on viral load and immunologic parameters in HIV-positive patients. Methods: T cell subsets, p24, plasma cytokines, serum or plasma HIV-RNA, dosage, and antivirals were assessed in HIV-positive patients and negative controls receiving 6 weeks of phototherapy with UVB and in untreated controls. Results: Phototherapy improved skin conditions without significantly affecting T cell numbers. Plasma p24 increased 2-fold (P = .055) and HIV-RNA levels 4-fold (P = .022) 6 weeks from baseline in patients who entered the trial before March 1995. Later patients who were mostly receiving combination antiviral therapy showed a 4-fold reduction in serum HIV-RNA (P = .012) at 2 weeks. The effect of UVB on viral load at 6 weeks was dependent on the baseline level (P = .006). IL-10 increased and was inversely related to HIV-RNA levels (P = .0267). Conclusion: Phototherapy is associated with HIV load alterations, depending on patients' initial HIV-RNA, antiviral therapy, skin type, and UVL dosage.

Original languageEnglish (US)
Pages (from-to)48-60
Number of pages13
JournalJournal of the American Academy of Dermatology
Issue number1
StatePublished - 1999

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy'. Together they form a unique fingerprint.

Cite this